DAPTOMYCIN Labatec subst sèche 500 mg flac
7680666510025
CH-66651
J01XX09
08.01.9.
Reimbursement limitations:
DAPTOMYCINLA
Chez l'adulte dans le traitement des infections compliquées de la peau et des tissus mous …
1 / 3
google
Details
- Product number
- 6665102
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- Praeparatio cryodesiccata: daptomycinum 500 mg, natrii hydroxidum, pro vitro.
Articles (1)
Daptomycin Labatec 500 mg, poudre pour solution injectable ou pour perfusion
poudre pour solution injectable ou pour perfusion
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRC
|
500.0 MG | Substance | Wirkstoff (Principe actif) |
|
PRC
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 131.95
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/12/2020
Authorization holder
Labatec Pharma SA
1217 Meyrin
Authorization information
- Swissmedic authorization number
- 66651
- Drug name
- Daptomycin Labatec, poudre pour solution injectable ou pour perfusion
- Galenic form
- PULPA
- ATC Code
- J01XX09
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 23/01/2019
- Authorization expiration date
- 31/12/9999
- IT number
- 08.01.9.
- Domain
- Human medicine
Packaging details
- Description (FR)
- DAPTOMYCIN Labatec subst sèche 500 mg flac
- Description (DE)
- DAPTOMYCIN Labatec Trockensub 500 mg Durchstf
- Market launch
- 23/01/2019
- Narcotic (BTM)
- No